Efficacy and tolerability of hyaluronan (ialuset®) in the treatment of pressure ulcers: A multicentre, non-randomised, pilot study

Drugs in R and D

Volumn 8, Issue 5, 2007, Pages 267-273

  Barrois, Brigitte ^a   Carles, Muriel ^b   Rumeau, Michel ^b   Tell, Laurence ^c   Toussaint, Jean François ^d   Bonnefoy, Marc ^e   De Vathaire, Florent ^f  

^a CENTRE HOSPITALIER DE GONESSE   (France)

^b Serv Univ Psychiat l'Enfant l'A   (France)

^c Hopital Henry Gabrielle   (France)

^d Clinique du Cabirol   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID DERIVATIVE; IALUSET; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DECUBITUS; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FRANCE; GAUZE DRESSING; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

AGED; FEMALE; FRANCE; HUMANS; HYALURONIC ACID; MALE; OCCLUSIVE DRESSINGS; OINTMENTS; PILOT PROJECTS; PRESSURE ULCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 34548657242     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200708050-00001     Document Type: Article

References (18)

1. Allman RM. Pressure ulcer prevalence, incidence, risk factors and impact. Clin Geriatr Med 1997; 13: 421-36
2. Barrois B, Allaert FA, Colin D. A survey of pressure sore prevalence in hospitals in the greater Paris region. J Wound Care 1995 May; 4 (5): 234-6
3. Smith DM. Pressure ulcers in the nursing home. Ann Intern Med 1995; 123: 433-42
4. Thoroddsen A. Pressure sore prevalence: a national survey. J Clin Nurs 1999; 8: 170-9
5. Whittington K, Patrick M, Roberts JL. A national study of pressure ulcer prevalence and incidence in acute care hospitals. J Wound Ostomy Continence Nurs 2000; 27 (4): 209-15
6. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994; 130 (4): 489-93
7. Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200 (4904): 377-8
8. Winter GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-4
9. Winter GD. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200: 378-9
10. Harding KG, Morris HL, Patel GK. Science, medicine, and the future: healing chronic wounds. BMJ 2002; 324: 160-3
11. Hollisaz MT, Khedmat H, Yari F. A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693]. BMC Dermatol 2004; 4 (1): 18
12. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999; 7 (2): 79-89
13. Humbert P. City/hospital networks for leg ulcers and treatment with ialuset. Ann Dermatol Venereol 2002; 129 (10 Pt 2): 1231-4
14. Ortonne JP. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatol Treat 1996; 7: 75-81
15. National Pressure Ulcer Advisory Panel (NPUAP). Pressure ulcers prevalence, cost and risk assessment: consensus development conference statement. Decubitus 1989; 2 (2): 24-8
16. Breslow N, Day N. Statistical methods in cancer research: II. The design and analysis of cohort studies. IARC Sci Pub 1987; 82: 1-406
17. Rhodes RS, Heyneman CA, Culbertson VL, et al. Topical phenytoin treatment of stage II decubitus ulcers in the elderly. Ann Pharmacother 2001; 35: 675-81
18. Müller E, van Leen MWF, Bergemann R. Economic evaluation of collagenase-containing ointment and hydrocolloid dressing in the treatment of pressure ulcers. Pharmacoeconomics 2001; 19 (12): 1209-16